Local Medical Device Production Gains Momentum at UCT

By HEOR Staff Writer

June 1, 2026

local medical device production

The drive toward local medical device production gained major momentum when the University of Cape Town’s Biomedical Engineering Research Centre obtained a manufacturing licence from the South African Health Products Regulatory Authority.

Breaking Import Dependencies

This authorisation enables the production, distribution, and wholesale of registered medical devices, moving locally designed technologies from research labs into everyday clinical use across South Africa and easing long-standing reliance on imported equipment.

Procedures were aligned with SAHPRA requirements and international quality standards equivalent to ISO 13485, creating an audited framework that supports ethical deployment and reduces external supply risks while advancing local medical device production capacity.

Boosting Regional Healthcare Access

The licence underpins cost-effective, context-appropriate solutions that cut import costs and improve market access, with prototypes expected to reach public hospitals within 18–24 months and contribute to broader health-system resilience.

Reference url

Recent Posts

Lingjian Morphology Diagnostics
Lingjian Morphology Diagnostics Transforming Clinical Laboratory Practices

By HEOR Staff Writer

June 22, 2026

Lingjian Morphology Diagnostics transforms microscopic analysis in clinical laboratories by uniting image interpretation, cell classification, morphological description, target localization, and natural language interaction within a single vision-language architecture. Developed to overcome pract...
Joint Scientific Consultation EU
Joint Scientific Consultation EU Strategies for Medical Device Companies

By João L. Carapinha

June 19, 2026

The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...
EU Joint Clinical Assessment
Insights on EU Joint Clinical Assessment for High-Risk Medical Devices

By João L. Carapinha

June 19, 2026

EU Joint Clinical Assessment is a distinct, harmonised process that operates separately from CE marking. It produces comparative clinical evidence on selected high-risk devices to support more consistent national reimbursement decisions across EU member states. Insights from the